ABM vs HLIO

ABM's Piotroski F-Score of 5/9 indicates a stable but not strong financial health, with no Altman Z-Score available to assess bankruptcy risk. The stock trades at $38.77, significantly above its Graham Number of $41.41 and well below its intrinsic value estimate of $18.13, suggesting overvaluation relative to conservative metrics. Despite a 6.1% YoY revenue growth, earnings have declined by 7.2% YoY, and recent quarters have consistently missed estimates with an average surprise of -12.45%. Insider selling totaling $1.81M in the last six months further undermines confidence, while technical trends remain bearish.

HLIO exhibits a stark divergence between its deterministic value and its growth trajectory. With a Piotroski F-Score of 4/9, the company's financial health is stable but lacks strong momentum. The current price of $69.18 trades at a significant premium to both the Graham Number ($30.3) and the Intrinsic Value ($42.77), though this is partially mitigated by a PEG ratio of 1.03 and a substantial reduction in Forward P/E. While analyst sentiment is strongly bullish, bearish technical trends and insider selling suggest a period of consolidation or correction may be imminent.